Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Sandoz expects the settlement, which is subject to approval from a Pennsylvania federal court, to be finalized before the end of the year. Those involved in the settlement have the right to opt ...

Sandoz Group said it would pay $275 million to settle claims from some plaintiffs in a generics drug pricing antitrust lawsuit in the U.S. The Swiss generics-medicine company said Tuesday that it ...

Sandoz (SDZNY) announced a number of steps to resolve the US Generic Drug Antitrust Class Action Litigation. Following the previously announced settlements with the US Department of Justice in ...

(RTTNews) - Sandoz Group AG (SDZNY), a Swiss generic and biosimilar medicines maker, announced Tuesday that it has agreed to pay $275 million to the class of end payer plaintiffs to resolve legacy ...

Swiss generic medicines firm Sandoz on Tuesday said it had reached a $275 million settlement with plaintiffs in a legacy US generic drug antitrust lawsuit. Sandoz and subsidiary Fougera ...

Sandoz US has entered into a settlement agreement with the class of end payer plaintiffs for USD 275 million Provision of USD 265 million taken to cover potential additional settlement costs with ...

Swiss generic and biosimilar medicines major Sandoz (SIX: SDZ) today announced a number of steps to resolve the US Generic Drug Antitrust Class Action Litigation. Following the previously announced ...